Literature DB >> 23180175

The relationship between cortisol and verbal memory in the early stages of Huntington's disease.

Christopher A Shirbin1, Phyllis Chua, Andrew Churchyard, Anthony J Hannan, Georgia Lowndes, Julie C Stout.   

Abstract

Hypothalamic pituitary adrenal (HPA) axis hyperactivity has been linked to learning and memory difficulties in a range of neurodegenerative and neuropsychiatric conditions. In Huntington's disease (HD), both declines in learning and memory and HPA axis dysfunction are present early in the disease. However, the relationship between specific learning and memory deficits and HPA axis functioning in HD has not been examined. The aim of this study was to investigate cortisol levels in relation to verbal learning and memory in pre-diagnosed (pre-HD) participants and patients at the early stages of diagnosed HD (early-HD). Cortisol concentration was assayed in saliva samples from 57 participants (17 early-HD, 20 pre-HD, and 20 controls) at four time-points across a 24-h period. Verbal memory was assessed using the California Verbal Learning Test-Second Edition (CVLT-II). We focused statistical analyses on the late evening cortisol concentration, and examined cortisol levels and verbal memory function in relation to diagnostic group (control, pre-HD, early-HD), and in a separate set of analyses combining pre-HD and early-HD (and excluding controls) we also examined cortisol and verbal memory performance in relation to the severity of HD-related motor signs. Of these two classification approaches, HD motor sign severity was more strongly associated with high evening cortisol levels and both reduced information encoding and memory retrieval. Separately, there was also a trend of higher cortisol levels in pre-HD. The findings suggest hypercortisolism and the underlying pathological changes may begin many years before a clinical diagnosis is made, but the memory decline associated with HPA axis disturbance may only become detectable once motor signs become pronounced.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23180175     DOI: 10.1007/s00415-012-6732-y

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  52 in total

1.  Measurement of late-night salivary cortisol with an automated immunoassay system.

Authors:  Michael Vogeser; Jürgen Durner; Ewald Seliger; Christoph Auernhammer
Journal:  Clin Chem Lab Med       Date:  2006       Impact factor: 3.694

2.  A global measure of perceived stress.

Authors:  S Cohen; T Kamarck; R Mermelstein
Journal:  J Health Soc Behav       Date:  1983-12

Review 3.  Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders.

Authors:  R M Sapolsky
Journal:  Arch Gen Psychiatry       Date:  2000-10

4.  Progressive alterations in the hypothalamic-pituitary-adrenal axis in the R6/2 transgenic mouse model of Huntington's disease.

Authors:  Maria Björkqvist; Asa Petersén; Karl Bacos; Jeremy Isaacs; Per Norlén; Joana Gil; Natalija Popovic; Frank Sundler; Gillian P Bates; Sarah J Tabrizi; Patrik Brundin; Hindrik Mulder
Journal:  Hum Mol Genet       Date:  2006-04-13       Impact factor: 6.150

5.  Increased hypothalamic-pituitary-adrenal axis activity in Huntington's disease.

Authors:  N Ahmad Aziz; Hanno Pijl; Marijke Frölich; A W Maurits van der Graaf; Ferdinand Roelfsema; Raymund A C Roos
Journal:  J Clin Endocrinol Metab       Date:  2009-01-27       Impact factor: 5.958

6.  Neuropsychological characteristics of Huntington's disease carriers: a double blind study.

Authors:  N K Rosenberg; S A Sørensen; A L Christensen
Journal:  J Med Genet       Date:  1995-08       Impact factor: 6.318

7.  Increased cortisol levels in aging and Alzheimer's disease in postmortem cerebrospinal fluid.

Authors:  D F Swaab; F C Raadsheer; E Endert; M A Hofman; W Kamphorst; R Ravid
Journal:  J Neuroendocrinol       Date:  1994-12       Impact factor: 3.627

8.  Cerebrospinal fluid correlates of depression in Huntington's disease.

Authors:  R Kurlan; E Caine; A Rubin; C B Nemeroff; G Bissette; R Zaczek; J Coyle; F J Spielman; C Irvine; I Shoulson
Journal:  Arch Neurol       Date:  1988-08

9.  A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length.

Authors:  D R Langbehn; R R Brinkman; D Falush; J S Paulsen; M R Hayden
Journal:  Clin Genet       Date:  2004-04       Impact factor: 4.438

10.  Atypical evening cortisol profile induces visual recognition memory deficit in healthy human subjects.

Authors:  Heather Gilpin; Daniel Whitcomb; Kwangwook Cho
Journal:  Mol Brain       Date:  2008-08-21       Impact factor: 4.041

View more
  7 in total

Review 1.  Progress in Huntington's disease: the search for markers of disease onset and progression.

Authors:  Sarah Mason; Roger A Barker
Journal:  J Neurol       Date:  2015-03-21       Impact factor: 4.849

Review 2.  A Glimpse of Molecular Biomarkers in Huntington's Disease.

Authors:  Silvia Martí-Martínez; Luis M Valor
Journal:  Int J Mol Sci       Date:  2022-05-12       Impact factor: 6.208

3.  Normalizing glucocorticoid levels attenuates metabolic and neuropathological symptoms in the R6/2 mouse model of huntington's disease.

Authors:  Brett D Dufour; Jodi L McBride
Journal:  Neurobiol Dis       Date:  2018-10-05       Impact factor: 5.996

4.  Corticosterone dysregulation exacerbates disease progression in the R6/2 transgenic mouse model of Huntington's disease.

Authors:  Brett D Dufour; Jodi L McBride
Journal:  Exp Neurol       Date:  2016-07-02       Impact factor: 5.330

5.  A 24-Hour Study of the Hypothalamo-Pituitary Axes in Huntington's Disease.

Authors:  Eirini Kalliolia; Edina Silajdžić; Rajasree Nambron; Seán J Costelloe; Nicholas G Martin; Nathan R Hill; Chris Frost; Hilary C Watt; Peter Hindmarsh; Maria Björkqvist; Thomas T Warner
Journal:  PLoS One       Date:  2015-10-02       Impact factor: 3.240

6.  Hair and salivary cortisol and their relationship with lifestyle, mood and cognitive outcomes in premanifest Huntington's disease.

Authors:  Travis Cruickshank; Tenielle Porter; Simon M Laws; Mel Ziman; Danielle M Bartlett
Journal:  Sci Rep       Date:  2021-03-09       Impact factor: 4.379

Review 7.  A Critical Evaluation of Wet Biomarkers for Huntington's Disease: Current Status and Ways Forward.

Authors:  Edina Silajdžić; Maria Björkqvist
Journal:  J Huntingtons Dis       Date:  2018
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.